Category: Clinical Trials

Medical science researcher performing scientific test

March 4, 2019

Press Releases Clinical Trials Start-ups PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452

PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452...

MORE >
women all wearing pink with breast cancer ribbon holding hands above their heads

August 6, 2020

Duke News Clinical Trials New Duke vaccine ‘works beautifully’ against breast cancer

New research out of Duke University could help the thousands...

MORE >

March 19, 2019

Medicine Clinical Trials Start-ups PhaseBio Reports Full Results from Phase 1 Clinical Trial

PhaseBio Pharmaceuticals, Inc. (NASDAQ: PHAS) announced today that results from their Phase...

MORE >
Eric Benner, Tellus Therapeutics speaking to people attending Invented at Duke, 2018

October 22, 2020

Duke Innovations Medicine Clinical Trials Start-ups Tellus Receives Orphan Drug/Rare Pediatric Disease Designations

With No Approved Treatments for Diffuse White Matter Injury in...

MORE >

April 17, 2019

Clinical Trials Start-ups Precision Announces Dosing of First Patient

Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to...

MORE >
Young female scientist holding liquid sample

July 12, 2019

Press Releases Clinical Trials Start-ups PhaseBio: Positive Results from Phase 2a Clinical Trial of PB2452

PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial...

MORE >

August 7, 2019

Clinical Trials Start-ups Polarean Enrols First Patient At University Of Cincinnati Trial Site

Polarean Imaging PLC on Monday announced enrolment of the first...

MORE >
TRND Pompe

February 2, 2018

Duke Innovations Press Releases Clinical Trials Pompe Gene Therapy Advances to Clinical Trials

[Orginially posted on National Center for Advancing Translational Sciences] NCATS Therapeutics for...

MORE >

August 14, 2019

Clinical Trials Start-ups PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting

PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on...

MORE >